Cargando…

Interleukin-17 cytokines: Effectors and targets in psoriasis—A breakthrough in understanding and treatment

The IL-17 cytokine family comprising IL-17A to IL-17F and receptor subunits IL-17RA to IL-17RE represents a genetically ancient intercellular network regulating local tissue homeostasis. Its pivotal role in antifungal defense and its central position in the pathogenesis of inflammatory diseases incl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prinz, Immo, Sandrock, Inga, Mrowietz, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037256/ https://www.ncbi.nlm.nih.gov/pubmed/31727784 http://dx.doi.org/10.1084/jem.20191397

Ejemplares similares

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

Interleukin-17 is disease promoting in early stages and protective in late stages of experimental periodontitis
por: Wilharm, Anneke, et al.
Publicado: (2022)

MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development
por: Sandrock, Inga, et al.
Publicado: (2015)

The role of the interleukin‐23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis
por: Egeberg, A., et al.
Publicado: (2020)

A Practical Guide to the Management of Oral Candidiasis in Patients with Plaque Psoriasis Receiving Treatments That Target Interleukin-17
por: Armstrong, April W., et al.
Publicado: (2022)

Revisiting the interleukin 17 family of cytokines in psoriasis: pathogenesis and potential targets for innovative therapies
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2023)

Interleukin-17A and Keratinocytes in Psoriasis
por: Furue, Masutaka, et al.
Publicado: (2020)

Interleukin-10 improves stroke outcome by controlling the detrimental Interleukin-17A response
por: Piepke, Marius, et al.
Publicado: (2021)

IL-17A–producing γδT cells promote muscle regeneration in a microbiota-dependent manner
por: Mann, Alexander O., et al.
Publicado: (2022)

The Role of IL-17 Cytokines in Psoriasis
por: Mosca, Megan, et al.
Publicado: (2021)

Whodunit? The Contribution of Interleukin (IL)-17/IL-22-Producing γδ T Cells, αβ T Cells, and Innate Lymphoid Cells to the Pathogenesis of Spondyloarthritis
por: Reinhardt, Annika, et al.
Publicado: (2018)

Management der Psoriasis
por: Mrowietz, Ulrich
Publicado: (2021)

The Interleukin-17 Family of Cytokines in Breast Cancer
por: Fabre, Joseph Antoine Salvator, et al.
Publicado: (2018)

Interleukins 20 and 8 – less widely known cytokines in psoriasis
por: Kutwin, Magdalena, et al.
Publicado: (2022)

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells
por: Singh, Bhagirath, et al.
Publicado: (2013)

Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities
por: Menter, Alan, et al.
Publicado: (2021)

Association of genetic polymorphism of interleukin-17A & interleukin-17F with susceptibility of psoriasis
por: Kaur, Rajinder, et al.
Publicado: (2018)

Inflammatory bowel disease in patients with psoriasis treated with interleukin-17 inhibitors
por: Fieldhouse, Keira A, et al.
Publicado: (2020)

Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases
por: Wasilewska, Agnieszka, et al.
Publicado: (2016)

Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
por: Meehan, Eileen Victoria, et al.
Publicado: (2022)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
por: Cauli, Alberto, et al.
Publicado: (2015)

Secukinumab - First in Class Interleukin-17A Inhibitor for the Treatment of Psoriasis
por: Godse, Kiran
Publicado: (2017)

Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways
por: Tollenaere, M.A.X., et al.
Publicado: (2021)

Impact of Adalimumab Treatment on Interleukin-17 and Interleukin-17 Receptor Expression in Skin and Synovium of Psoriatic Arthritis Patients with Mild Psoriasis
por: Bolt, Janne W., et al.
Publicado: (2022)

The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
por: Schön, Michael P., et al.
Publicado: (2018)

The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
por: Brembilla, Nicolo Costantino, et al.
Publicado: (2018)

Microbiota-dependent expansion of testicular IL-17-producing Vγ6(+) γδ T cells upon puberty promotes local tissue immune surveillance
por: Wilharm, Anneke, et al.
Publicado: (2020)

Out of the shadow of interleukin-17A: the role of interleukin-17F and other interleukin-17 family cytokines in spondyloarthritis
por: Yeremenko, Nataliya
Publicado: (2021)

The role of IL‐23 and the IL‐23/T(H)17 immune axis in the pathogenesis and treatment of psoriasis
por: Girolomoni, G., et al.
Publicado: (2017)

Genetic models reveal origin, persistence and non-redundant functions of IL-17–producing γδ T cells
por: Sandrock, Inga, et al.
Publicado: (2018)

Dimethyl fumarate (DMF) vs. monoethyl fumarate (MEF) salts for the treatment of plaque psoriasis: a review of clinical data
por: Landeck, Lilla, et al.
Publicado: (2018)

Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11
por: Metcalfe, Riley D., et al.
Publicado: (2020)

Interleukin-23 instructs protective multifunctional CD4 T cell responses after immunization with the Mycobacterium tuberculosis subunit vaccine H1 DDA/TDB independently of interleukin-17A
por: Ritter, Kristina, et al.
Publicado: (2021)

Transcriptional regulation on effector T cells in the pathogenesis of psoriasis
por: Qu, Yuying, et al.
Publicado: (2023)

Level of inflammatory cytokines tumour necrosis factor α, interleukins 12, 23 and 17 in patients with psoriasis in the context of metabolic syndrome
por: Pirowska, Magdalena, et al.
Publicado: (2019)

Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients
por: Nakajima, Hideki, et al.
Publicado: (2011)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Biology of recently discovered cytokines: Interleukin-17 – a unique inflammatory cytokine with roles in bone biology and arthritis
por: Gaffen, Sarah L
Publicado: (2004)

Effectiveness and Safety of Anti-interleukin-17 Therapies in Elderly Patients with Psoriasis
por: PHAN, Céline, et al.
Publicado: (2020)

Relevance of Inflammatory Cytokine mRNA Expression of Tumour Necrosis Factor- Alpha (TNF α), Interleukin 17A (IL 17A) and Interleukin 6 (IL 6) in Indian Patients with Psoriasis
por: Shah, Saiqa R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nkn9to8ttfc3b952p56m423ts7